NEW YORK, July 16, 2026
DarioHealth Corp. has secured a major commercial milestone after being selected by another Fortune 50 employer to provide its AI-powered integrated cardiometabolic care platform for employees managing diabetes and hypertension. The new agreement will make Dario’s digital health platform available to more than 100,000 eligible employees, representing the company’s fifth Fortune 50 client and highlighting the growing adoption of AI-driven chronic disease management among large employers. Scheduled to launch in Fall 2026, the program is expected to begin contributing recurring revenue by the end of the year, with broader commercial impact anticipated throughout 2027. The contract further validates increasing employer demand for comprehensive digital healthcare solutions capable of improving clinical outcomes while reducing healthcare costs through personalized, technology-enabled care. By combining connected medical devices, AI-powered analytics, personalized health coaching, and behavioral support within a single ecosystem, Dario continues to strengthen its position as a leader in next-generation digital therapeutics and chronic disease management.
AI-Powered Platform Expands Cardiometabolic Care
The newly awarded program will provide eligible employees with access to Dario’s integrated cardiometabolic care platform, designed specifically to support individuals living with diabetes, hypertension, and related metabolic conditions. Unlike traditional healthcare solutions that address each chronic disease independently, Dario’s platform delivers a unified care experience that combines connected monitoring devices, AI-driven clinical insights through DarioIQ™, personalized coaching, and evidence-based behavioral interventions. Powered by more than 13 billion proprietary longitudinal healthcare data points collected over the past decade, the platform continuously analyzes biometric, behavioral, and clinical information to personalize recommendations for every individual. This data-driven approach enables earlier intervention, improved patient engagement, and more effective management of multiple chronic conditions simultaneously. As healthcare organizations increasingly prioritize preventive care and digital transformation, integrated AI-enabled solutions such as Dario’s are emerging as valuable tools for improving long-term patient outcomes while reducing avoidable healthcare utilization.
Growing Employer Demand Drives Digital Health Adoption
The latest Fortune 50 agreement demonstrates a broader shift among employers toward outcomes-based chronic condition management as healthcare costs continue to rise. Diabetes and hypertension, which frequently coexist, collectively account for more than $500 billion in annual healthcare expenditures across the United States, creating substantial financial pressure for employers and health plans. Dario’s integrated model addresses these interconnected conditions within a single platform, helping patients manage multiple health challenges more efficiently while simplifying care delivery for employers. Clinical evidence cited by the company indicates that individuals simultaneously managing diabetes, hypertension, and excess weight through Dario’s platform achieve better health outcomes than those addressing a single condition alone. By reducing fragmented care and encouraging sustained engagement, the platform supports improved disease control, healthier behaviors, and greater workforce productivity while lowering long-term medical costs. The addition of another Fortune 50 customer further reinforces Dario’s expanding presence among major enterprise organizations seeking scalable digital healthcare solutions.
Advertisement
Strategic Growth Strengthens Dario’s Healthcare Technology Leadership
With nearly one-quarter of its customer base now consisting of Fortune 500 companies, DarioHealth continues to accelerate its commercial expansion within the rapidly evolving AI-powered healthcare technology sector. The company’s integrated platform supports a broad range of chronic conditions beyond cardiometabolic disease, including weight management, musculoskeletal disorders, and behavioral health, enabling healthcare organizations to consolidate multiple care programs into a single digital ecosystem. By combining artificial intelligence, personalized coaching, connected devices, and provider-supported clinical care, Dario is helping employers transition toward proactive, data-driven healthcare delivery models that emphasize prevention, engagement, and measurable outcomes. As demand for intelligent digital health platforms continues to grow globally, the latest Fortune 50 contract represents another important validation of DarioHealth’s technology strategy and positions the company for continued commercial momentum throughout 2026 and beyond, while advancing innovation in AI-enabled chronic disease management and population health.
Source: DarioHealth press release
